ARAGON SURGICAL RF SYSTEM - 5MM LAPAROSCOPIC INSTRUMENT
K110824 · Aragon Surgical, Inc. · GEI · Jul 11, 2011 · General, Plastic Surgery
Device Facts
| Record ID | K110824 |
| Device Name | ARAGON SURGICAL RF SYSTEM - 5MM LAPAROSCOPIC INSTRUMENT |
| Applicant | Aragon Surgical, Inc. |
| Product Code | GEI · General, Plastic Surgery |
| Decision Date | Jul 11, 2011 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 878.4400 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The Aragon Surgical Caiman 5 Laparoscopic Instrument is a dedicated bipolar electrosurgical instrument intended for use in general surgical and gynecologic laparoscopic procedures where ligation and division of vessels is desired. The instrument creates a seal by the application of bipolar electrosurgical RF energy to vascular structures (vessels) interposed between the jaws of the device. A cutting blade is actuated for the division of tissue. Indications for use include general laparoscopic procedures, including urologic, vascular, thoracic, and thoracsocopic, and gynecological laparoscopic procedures where ligation and division of vessels is performed. These procedures include: laparoscopically assisted vaginal hysterectomies, Nissen fundoplication, colectomy, adhesiolysis, oophorectomy etc. The Aragon Surgical Caiman 5 Laparoscopic Instrument can be used on vessels up to and including 7mm, and tissue bundles as large as will fit in the jaws of the instrument. The Aragon Surgical Lektrafuse RF System has not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.
Device Story
Sterile, single-use bipolar electrosurgical instrument; used in laparoscopic/open surgery for vessel sealing, blunt dissection, grasping, and tissue division. Operates with Aragon Surgical Lektrafuse RF Generator; applies bipolar RF energy to vascular structures between jaws; features integrated manual cutting blade. Used by surgeons in OR settings. Output is sealed/divided tissue. Benefits include efficient hemostasis and tissue management during minimally invasive procedures.
Clinical Evidence
Bench and pre-clinical evaluations performed. No clinical trial data provided.
Technological Characteristics
Bipolar electrosurgical instrument; single-use; sterile. Utilizes bipolar RF energy for vessel sealing and mechanical cutting blade for tissue division. Designed for use with Aragon Surgical Lektrafuse RF Generator. Dimensions accommodate vessels up to 7mm.
Indications for Use
Indicated for patients undergoing general, gynecologic, urologic, vascular, thoracic, and thoracoscopic laparoscopic procedures requiring vessel ligation and tissue division. Compatible with vessels up to 7mm and tissue bundles fitting within device jaws. Contraindicated for tubal sterilization or tubal coagulation.
Regulatory Classification
Identification
An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.
Predicate Devices
- Aragon Surgical RF System (K090306)
- Valleylab LigaSure 5mm Laparoscopic Sealer and Divider (K031011)
- Valleylab LigaSure 5mm Blunt Tip Laparoscopic Sealer and Divider (K092879)
- Valleylab LigaSure Vessel Sealing System (K981916)
- ValleyLab ForceTriad RF Generator (K070612)
Related Devices
- K090306 — ARAGON SURGICAL RF SYSTEM L2 INSTRUMENT · Aragon Surgical, Inc. · Jun 18, 2009
- K140839 — CAIMAN SEAL AND CUT TECHNOLOGY · Aesculap, Inc. · Apr 28, 2014
- K202938 — Aesculap Caiman 5 Seal and Cut Technology System · Aesculap, Inc. · Oct 30, 2020
- K062525 — REPROCESSED LIGASURE VESSEL SEALER/DIVIDER · Ascent Healthcare Solutions · May 16, 2007
- K203461 — Aesculap Caiman 12 Seal and Cut Technology System · Aesculap, Inc. · Dec 18, 2020
Submission Summary (Full Text)
{0}------------------------------------------------
Aragon Surgical-Caiman 5 Laparoscopic Instrument Premarket Notification
JUL 1 1 2011
## SECTION 5
# 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
# REGULATORY AUTHORITY
Safe Medical Devices Act of 1990, 21 CFR 807.92
#### COMPANY NAME/CONTACT
Alan Curtis Aragon Surgical, Inc. 1810 Embarcadero Road, Suite B Palo Alto, CA 94303
### NAME OF DEVICE
| Trade Name: | Aragon Surgical RF System<br>Caiman 5 Laparoscopic Instrument |
|------------------------|-------------------------------------------------------------------------------------|
| Common Name: | Electrosurgical System |
| Device Product Code: | GEI |
| Classification Name: | Electrosurgical Cutting and Coagulation Device and<br>Accessories (21 CFR 878.4400) |
| Device Panel: | General Surgery/Restorative Devices |
| Device Classification: | Class II |
#### PREDICATE DEVICES
- Aragon Surgical RF System (K090306) .
- ValleylabLigaSure™ LigaSure 5mm Laparoscopic Sealer . and Divider (K031011)
- ValleylabLigaSure™ LigaSure 5mm Blunt Tip Laparoscopic Sealer . and Divider (K092879)
- ValleylabLigaSure Vessel Sealing System (K981916) .
- ValleyLab ForceTriad RF Generator (K070612) .
CONFIDENTIAL .
{1}------------------------------------------------
### DEVICE DESCRIPTION
The Aragon Surgical Caiman 5 Laparoscopic Instrument is provided as a sterile, single use device. The device is capable of vessel sealing, blunt dissection, grasping and dividing tissue enclosed within its iaws during open and laparoscopic procedures. The device is designed to be used with the Aragon Surgical RF Generator (K093075) and creates vessel ligation by the application of bipolar electrical RF energy and tissue division with a cutting blade.
The Aragon Surgical Lektrafuse RF Generator is designed to be used with Aragon Surqical RF instrumentation only. The Aragon Surgical Lektrafuse RF Generator is not compatible with any other handheld RF surgical instrumentation.
## INDICATION FOR USE STATEMENT
The Aragon Surgical Caiman 5 Laparoscopic Instrument is a dedicated bioolar electrosurgical instrument intended for use in general surgical and gynecologic laparoscopic procedures where ligation and division of vessels is desired. The instrument creates a seal by the application of bipolar electrosurgical RF energy to vascular structures (vessels) interposed between the jaws of the device. A cutting blade is actuated for the division of tissue.
Indications for use include general laparoscopic procedures, including urologic, vascular, thoracic, and thoracsocopic, and gynecological laparoscopic procedures where ligation and division of vessels is performed. These procedures include: laparoscopically assisted vaginal hysterectomies, Nissen fundoplication, colectorny, adhesiolysis, oophorectomy etc.
The Aragon Surgical Caiman 5 Laparoscopic Instrument can be used on vessels up to and including 7mm, and tissue bundles as large as will fit in the iaws of the instrument.
The Aragon Surgical Lektrafuse RF System has not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.
### SUBSTANTIAL EQUIVALENCE COMPARISON
### Comparison to Predicate Devices
The technological characteristics and indications for use of the Aragon Surgical Caiman 5 Laparoscopic Instrument are similar to those of the cited predicate electrosurgical devices, as well as the similar RF Systems distributed commercially by other manufacturers. These devices are equivalent in terms of design, materials, principal of operation, and product specifications. Any differences between the Aragon Surgical device and the predicate devices do not raise new issues regarding safety or effectiveness.
### PERFORMANCE DATA
Results of bench and pre-clinical evaluations were used to demonstrate that the Aragon Surgical Lektrafuse RF Generator and Caiman 5 Laparoscopic Instrument are substantially equivalent to the predicate devices and meets design, safety, and effectiveness criteria.
CONFIDENTIAL
{2}------------------------------------------------
Aragon Surgical-Caiman 5 Laparoscopic Instrument Premarket Notification
## CONCLUSION
Based on the design, materials, function, intended use, and pre-clinical evaluation, the Aragon Surgical Lektrafuse RF Generator and Caiman 5 Laparoscopic Instrument are substantially equivalent to the devices currently marketed under the Federal Food, Drug and Cosmetic Act. Sufficient data were obtained to demonstrate that the device is substantially equivalent to the predicate devices and raises no new safety or effectiveness issues. Therefore, safety and effectiveness are reasonably assured, justifying 510(k) clearance for commercial sale.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Aragon Surgical. Inc. % Mr. Alan Curtis 3617 Scott Street San Francisco, California 94123
# JUL 1 1 2011
Re: K110824
Trade/Device Name: Aragon Caiman 5 Laparoscopic Instrument, Model 50136 Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: June 29, 2011 Received: July 5, 2011
Dear Mr. Curtis:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may ... publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
{4}------------------------------------------------
Page 2 - Mr. Alan Curtis
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
#### SECTION 4
#### INDICATIONS FOR USE STATEMENT
510(k) Number:
Device Name:
Aragon Surgical Lektrafuse RF System-Caiman 5 Laparoscopic Instrument
Indications for Use:
The Aragon Surgical Caiman 5 Laparoscopic Instrument is a dedicated bipolar electrosurgical instrument intended for use in general surgical and gynecologic laparoscopic procedures where ligation and division of vessels is desired. The instrument creates a seal by the application of bipolar electrosurgical RF energy to vascular structures (vessels) interposed between the jaws of the device. A cutting blade is actuated for the division of tissue.
Indications for use include general laparoscopic procedures, including urologic, vascular, thoracic, and thoracsocopic, and gynecological laparoscopic procedures where ligation and division of vessels is performed. These procedures include: laparoscopically assisted vaginal hysterectomies, Nissen fundoplication, colectomy, adhesiolysis, oophorectomy etc.
The Aragon Surgical Caiman 5 Laparoscopic Instrument can be used on vessels up to and including 7mm, and tissue bundles as large as will fit in the jaws of the instrument.
The Aragon Surgical Lektrafuse RF System has not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Prescription Use X = _ ________________________________________________________________________________________________________________________________________________________________________ (Per 21 CFR 801.109)
Over-The-Counter Use
### Concurrence of CDRH. Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K110824
CONFIDENTIAL
000015